Bausch Health Companies Inc.BHC

NYSEHealthcarePharmaceuticals$4.96-1.78%

A specialty pharmaceutical manufacturer focused on branded and generic drugs across gastroenterology, dermatology, neurology, and eye health. The company operates globally and generates revenue from a portfolio of legacy products and prescription therapies, while continuing to manage a large debt lo...

Market Cap: $1.8B52W Range: $4.25 – $8.69

Congressional Interest in Bausch Health Companies Inc. (BHC)

2 members of Congress have disclosed 7 trades in Bausch Health Companies Inc. (BHC), a Healthcare company. The buy/sell breakdown shows 3 purchases versus 4 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.